CVS Health Poised to Reenter ACA Marketplaces
Aetna got out of the ACA marketplace business in 2018. Now CVS Health, which completed its acquisition of the insurance company in late 2018, is hopping back in and will brand the policies as a “CVS Health-Aetna” product for the first time.
Aetna got out of the ACA marketplace business in 2018. Now CVS Health, which completed its acquisition of the insurance company in late 2018, is hopping back in and will brand the policies as a “CVS Health-Aetna” product for the first time, Karen S. Lynch, the company’s new president and CEO, said during an earnings call last month.
“As the ACA has evolved, there is evidence of market stabilization and remedies to earlier structural issues,” Lynch said during the Feb. 16 call. “It is now time for us to participate in these markets.”
Lynch said CVS Health would start selling coverage that would start in January 2022, but she shared no details about how many markets the company might sell CVS Health-Aetna coverage in or which ones.
She noted that the ACA marketplace market was a big one of 10 to 15 million people. After a Supreme Court ruling favoring insurers, CVS Health was among those that received a hefty ACA risk corridor payment. The company booked a $307 million risk corridor payment in 2020.
The ACA marketplace plans may also benefit from President Joe Biden’s proposal to increase the subsidies that lower premium costs for Americans who buy ACA marketplace coverage.
CVS Health is a huge ($286.7 billion revenues last year), publicly traded company, but like many of its competitors, it has seen the proportion of its government business (Medicare Advantage, Medicaid) grow relative to its commercial business.
For example, the number of people in its insured commercial plans decreased from 3,591,000 in 2019 to 3,258,000 in 2020, a difference of 333,000, or 9.3%, according to year-end results posted at the time of the earnings call. Meanwhile, the number of people in its Medicare Advantage plans increased from 2,321,000 in 2019 to 2,705,000 in 2020, an increase of 384,000, or 16.5%.
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
July 14th 2025Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic kidney disease (CKD) associated with type 2 diabetes. This new approval extends its use to a broader patient population.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
